Methotrexate and its therapeutic antagonists caffeine and theophylline, target a motogenic T-cell mechanism driven by thrombospondin-1 (TSP-1)

European Journal of Immunology
Toomas TalmeKarl-Gösta Sundqvist

Abstract

Methotrexate (MTX) is a widely used treatment for inflammatory diseases such as rheumatoid arthritis and psoriasis, based on the concept that it is immunosuppressive. Its mechanism of action, however, remains unclear, although it is thought to depend on adenosine. Caffeine and theophylline, which have several targets including adenosine receptors, have been shown to suppress the beneficial clinical effects of MTX. Here we show that MTX and caffeine and theophylline differentially affect a motogenic T-cell mechanism driven by endogenous thrombospondin-1 (TSP-1) and its receptor, low density lipoprotein receptor-related protein 1 (LRP1). MTX stimulated TSP-1 expression and the motogenic TSP-1/TSP-1 receptor mechanism in primary human T cells, hence mimicking IL-2 and CXCL12, which similar to MTX, dampen inflammatory disease. SiRNA-mediated gene silencing of TSP-1 and LRP1 inhibited this stimulatory effect. Caffeine and theophylline inhibited the TSP-1/TSP-1 receptor mechanism by inhibiting LRP1 expression. These results indicate that the effect of MTX on T cells is immunoregulatory rather than immunosuppressive, and suggest a pathway dependent on TSP-1/TSP-1 receptor interactions for the regulation of immune responses.

References

Sep 1, 1973·The Journal of Clinical Investigation·A Winkelstein
Apr 1, 1983·The Journal of Cell Biology·S L SchorB Winn
Aug 1, 1994·Immunity·T L WalunasJ A Bluestone
Aug 1, 1993·The Journal of Cell Biology·J S HerskovitsR B Vallee
Jan 5, 1996·The Journal of Biological Chemistry·A G GaoW A Frazier
Mar 1, 1996·The European Respiratory Journal·Z H JaffarJ Costello
Jul 10, 1998·Cell·S E CrawfordN Bouck
Mar 30, 2001·The Journal of Biological Chemistry·C HerreraR Franco
Mar 29, 2002·European Journal of Immunology·Shu Shun LiKarl-Gösta Sundqvist
Jul 27, 2002·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Karl Axel HartmannHans Bojar
Jul 31, 2002·The Journal of Biological Chemistry·Silvia GoicoecheaJoanne E Murphy-Ullrich
Nov 7, 2002·Carcinogenesis·Simone BoldtWalter Kolch
Jun 25, 2003·The Journal of Cell Biology·Anthony Wayne OrrJoanne E Murphy-Ullrich
Aug 12, 2003·The Journal of Biological Chemistry·Maria J CalzadaDavid D Roberts
Oct 17, 2003·Proceedings of the National Academy of Sciences of the United States of America·Guido BocciRobert S Kerbel
Jan 9, 2004·Nature·Thorsten R MempelUlrich H Von Andrian
Apr 20, 2004·The International Journal of Biochemistry & Cell Biology·Josephine C Adams, Jack Lawler
Nov 2, 2004·Nature Immunology·Stéphanie HuguesSebastian Amigorena
Jan 7, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Courtney M LappasJoel Linden
Jan 11, 2005·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Andrew JohnstonHelgi Valdimarsson
Jun 21, 2005·Journal of Cellular and Molecular Medicine·Anna LudlowJ Lawler
Jan 13, 2006·British Journal of Pharmacology·Victoria Boswell-SmithClive P Page
Mar 7, 2006·Nature Reviews. Drug Discovery·Kenneth A Jacobson, Zhan-Guo Gao
Jun 3, 2006·Developmental Cell·Eric MaciaTomas Kirchhausen
Aug 15, 2006·Immunological Reviews·Shimon SakaguchiTakashi Nomura
Apr 20, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Laurence LamyAlain Bernard

❮ Previous
Next ❯

Citations

Aug 6, 2019·Scandinavian Journal of Immunology·Jacek Hawiger, Jozef Zienkiewicz
Jun 20, 2019·Frontiers in Immunology·Pedro Rodríguez-JiménezEsteban Daudén
Dec 29, 2020·Frontiers in Immunology·Karl-Gösta Sundqvist
Jul 11, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Zhaohui HeMao Luo
Oct 31, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Juliano Marchi VieiraRoselia Maria Spanevello

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.